Targeting Farnesoid-X-Receptor: From Medicinal Chemistry to Disease Treatment

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|17|2|139-159

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.17, Iss.2, 2010-01, pp. : 139-159

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Medicinal Chemistry and Pharmacological Effects of Farnesoid X Receptor (FXR) Antagonists

By  

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 19, 2014-10 ,pp. : 2188-2205

Bentham Science Publishers

Access to resources Recommend Favorite

Farnesoid X receptor agonism – a new approach to the treatment of cholesterol gallstone disease

By Doggrell Sheila A  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 4, 2005-04 ,pp. : 535-538

Informa Healthcare

Access to resources Recommend Favorite

Editorial: (Thematic Issue: Medicinal Chemistry of Farnesoid X Receptor (FXR) Modulators: The-State-of-the-Art)

By  

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 19, 2014-10 ,pp. : 2127-2128

Bentham Science Publishers

Access to resources Recommend Favorite

Lepidozenolide from the liverwort Lepidozia fauriana acts as a farnesoid X receptor agonist

By Lin Hsiang-Ru  

Journal of Asian Natural Products Research, Vol. 17, Iss. 2, 2015-02 ,pp. : 149-158

Taylor & Francis Ltd

Access to resources Recommend Favorite

Beyond Bile Acids: Targeting Farnesoid X Receptor (FXR) with Natural and Synthetic Ligands

By  

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 19, 2014-10 ,pp. : 2129-2142

Bentham Science Publishers

Access to resources Recommend Favorite